Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial.
| Autor: | Dutton, Susan J.1 susan.dutton@csm.ox.ac.uk, Ferry, David R.2,3, Blazeby, Jane M.4,5, Abbas, Haider2, Dahle-Smith, Asa6, Mansoor, Wasat7, Thompson, Joyce8, Harrison, Mark9, Chatterjee, Anirban10, Falk, Stephen4, Garcia-Alonso, Angel11, Fyfe, David W.12, Hubner, Richard A.7, Gamble, Tina8, Peachey, Lynnda13, Davoudianfar, Mina13, Pearson, Sarah R.13, Julier, Patrick13, Jankowski, Janusz14, Kerr, Rachel13 |
|---|---|
| Zdroj: | Lancet Oncology. Jul2014, Vol. 15 Issue 8, p894-904. 11p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|